Chicago-Based G2.com Reaches Unicorn Status With Series D Round
June 30, 2021
Cooley advised G2.com, a software review site, on its $157 million Series D financing round, which brings its valuation to $1.1 billion. Lawyers Jon Gavenman and Sepideh Mousakhani led the Cooley team advising G2.com on the round.
Cooley advised C3.ai on its $748.65 million initial public offering of 17,825,000 shares of Class A common stock , which includes the full exercise of the underwriters’ option to purchase additional shares. C3.ai, whose securities now trade on the New York Stock Exchange under the symbol AI, is an enterprise artificial intelligence company. Partners Eric Jensen and Calise Cheng led the Cooley team.
Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy
June 24, 2020
Cooley advised clinical-stage biotechnology company Orca Bio on its $192 million Series D financing round, which was co-led by Lightspeed Venture Partners and an undisclosed investor. The round brings Orca’s total capital raised to nearly $300 million and values the company at more than $1 billion. Cooley partners Josh Seidenfeld and Mark Weeks led the team advising Orca.
Forty Seven Agrees to Sell to Gilead for $4.9 Billion
March 2, 2020
Cooley advised publicly traded clinical-stage immuno-oncology company Forty Seven on its agreement to sell to Gilead for $4.9 billion in all cash. Partners Jamie Leigh, Ben Beerle, Eric Jensen and John McKenna led the Cooley team advising Forty Seven on the transaction, which is expected close in Q2.